iCAD Inc is a United Statesâ€‘based company. The Company develops artificial intelligence solutions designed to support healthcare providers in the detection and diagnosis of cancer. The company focuses on providing clinically proven AI technologies that assist medical professionals in identifying cancer earlier, improving diagnostic accuracy, and enhancing workflow efficiency. Its solutions include platforms for cancer detection, breast density assessment, and risk evaluation, enabling clinicians to analyze medical images and support patient care decisions. The company leverages advanced data, clinical evidence, and AIâ€‘driven technologies to deliver tools that integrate into existing healthcare systems and assist in screening and diagnostic processes across global markets.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement and Estimates

More financial data

Market Closed - Nasdaq Other stock markets 21:00:00 16/07/2025 BST			5-day change	1st Jan Change
3.870 ^USD	+3.75%		-.--%	-

21/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from S&P TMI Index	CI
17/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Value Benchmark Index	CI

Market Cap	106M 92.28M 85.15M 78.49M 148M 10.17B 151M 1.02B 400M 4.98B 397M 388M 17.14B	P/E 2023	-9.35x	P/E 2024	-8.59x
Enterprise Value	88.75M 77.56M 71.57M 65.97M 124M 8.55B 127M 855M 336M 4.19B 333M 326M 14.41B	EV / Sales 2023	1.47x	EV / Sales 2024	1.6x
Free-Float	99.32%	Yield 2023 *	-	Yield 2024	-

21/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from S&P TMI Index	CI
17/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Value Benchmark Index	CI
17/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Growth Benchmark Index	CI
17/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell 3000E Value Benchmark	CI
17/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell 3000E Growth Benchmark	CI
17/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Growth Index	CI
17/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Index	CI
17/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Value Index	CI
17/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell 3000E Value Index	CI
17/07/25	RadNet, Inc. completed the acquistion of iCAD, Inc..	CI
17/07/25	RadNet's DeepHealth Unit Closes iCAD Acquisition	MT
16/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from NASDAQ Composite Index	CI
13/05/25	ICAD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI

17/04/25	RadNet's iCAD Deal to Expand its Digital Health Services and Geographic Presence, Truist Says	MT
17/04/25	BTIG Research Downgrades iCAD to Neutral From Buy	MT
19/07/23	Lake Street Adjusts Price Target on icad to $5 From $2.50, Maintains Buy Rating	MT
13/04/23	JMP Securities Adjusts iCAD's Price Target to $4 From $7, Keeps Outperform Rating	MT
04/04/23	Oppenheimer Adjusts iCAD Price Target to $4 From $5, Maintains Outperform Rating	MT

ICAD Share Price

Stocks

ICAD

US44934S2068

Advanced Medical Equipment & Technology

Valuation: ICAD

Latest news : ICAD

Analysts' recommendations: ICAD

Press Releases: ICAD

News in other languages: ICAD

Quotes and Performance

Course Extremes

Managers and Directors: ICAD

Latest insider transactions

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Income Statement and Estimates

08/07/25	ICAD Announces Proxy Advisory Firms ISS and Glass Lewis Recommend Stockholders Vote “FOR” Proposed Acquisition by RadNet, Inc.	AQ
03/06/25	ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD	BU
13/05/25	ICAD Reports Financial Results for First Quarter Ended March 31, 2025	AQ
29/04/25	ICAD Collaborates with Microsoft to provide access to its Mammography Solutions in Microsoft’s Precision Imaging Network (PIN)	AQ
17/04/25	ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD	BU

13/03/23	LA PREMIÈRE ÉTAPE DE L’OPÉRATION CONSISTE EN LA CESSION PAR ICAD…
26/04/21	CAC 40 : Les valeurs à suivre à Paris et en Europe
26/04/21	Les valeurs à suivre à Paris et en Europe (actualisé)
18/10/19	ICAD : annonce l’installation de la solution ProFound AI™ 2D pour la mammographie et pour la tomosynthèse (DBT) 3D au Centre d’Imagerie Paris Nord Sarcelles
25/01/19	Dow Jones Industrial Average : Wall Street attendue en hausse malgré Intel et les doutes sur la croissance

Manager	Title	Age	Since
Dana Brown CEO	Chief Executive Officer	61	09/03/2023
Mark Stolper DFI	Director of Finance/CFO	54	16/07/2025
Dave Katz SEC	Corporate Secretary	-	16/07/2025

Date	Insider	Type	Main position	Quantity	% Market Cap.
17/07/25	Andrew Sassine	Issuer sale	Director	1,553,657	5.8540%
17/07/25	Rakesh Patel	Issuer sale	Director	332,572	1.2531%
17/07/25	Michael Doyle	Issuer sale	Director	87,408	0.3293%

	2023	2024
Net sales	17.32M 15.13M 13.97M 12.87M 24.26M 1.67B 24.8M 167M 65.65M 817M 65.04M 63.61M 2.81B	19.61M 17.14M 15.81M 14.57M 27.47M 1.89B 28.08M 189M 74.34M 925M 73.64M 72.02M 3.18B
Net income	-4.85M -4.24M -3.91M -3.6M -6.79M -467M -6.94M -46.72M -18.38M -229M -18.2M -17.8M -787M	-5.62M -4.91M -4.53M -4.17M -7.87M -541M -8.04M -54.13M -21.29M -265M -21.09M -20.63M -912M
Net Debt	-21.21M -18.53M -17.1M -15.76M -29.71M -2.04B -30.37M -204M -80.41M -1B -79.65M -77.9M -3.44B	-16.84M -14.72M -13.58M -12.52M -23.6M -1.62B -24.12M -162M -63.86M -794M -63.26M -61.87M -2.73B

3 years	1.18	4.02
5 years	1.05	16.36
10 years	1.05	21.44

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ICAD	+3.75%	-.--%	-.--%	+87.86%	106M
THERMO FISHER SCIENTIFIC, INC.	-1.97%	+1.03%	+25.30%	+1.37%	198B
DANAHER CORPORATION	-0.58%	+2.40%	+4.64%	-14.27%	144B
INTUITIVE SURGICAL, INC.	-14.15%	-15.08%	-33.08%	-2.38%	122B
BOSTON SCIENTIFIC CORPORATION	-1.32%	-1.65%	-57.93%	-16.31%	65.44B
EDWARDS LIFESCIENCES CORPORATION	-2.40%	-7.03%	+12.54%	-7.47%	49.36B
SIEMENS HEALTHINEERS AG	-0.11%	+1.53%	-24.62%	-31.81%	44.75B
AGILENT TECHNOLOGIES, INC.	-3.41%	-2.11%	+12.98%	+11.17%	37.13B
WATERS CORPORATION	-2.44%	-1.98%	+24.27%	+36.75%	36.23B
GE HEALTHCARE TECHNOLOGIES INC.	-4.00%	-2.52%	-17.27%	-22.32%	28.69B
Average	-1.18%	-2.07%	-5.32%	+4.26%	72.62B
Weighted average by Cap.	-1.33%	-1.83%	-2.45%	-5.26%